nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—ABCB1—kidney cancer	0.111	1	CbGaD
Losartan—UGT1A1—Pazopanib—kidney cancer	0.0523	0.0968	CbGbCtD
Losartan—SLCO1B3—Paclitaxel—kidney cancer	0.0406	0.0752	CbGbCtD
Losartan—UGT1A1—Erlotinib—kidney cancer	0.0373	0.0691	CbGbCtD
Losartan—SLCO1B1—Pazopanib—kidney cancer	0.0362	0.067	CbGbCtD
Losartan—UGT1A1—Sorafenib—kidney cancer	0.0304	0.0562	CbGbCtD
Losartan—CYP3A5—Temsirolimus—kidney cancer	0.0303	0.0562	CbGbCtD
Losartan—ABCB1—Temsirolimus—kidney cancer	0.0198	0.0365	CbGbCtD
Losartan—CYP3A4—Everolimus—kidney cancer	0.0175	0.0324	CbGbCtD
Losartan—CYP2C8—Pazopanib—kidney cancer	0.0153	0.0284	CbGbCtD
Losartan—SLC22A12—nephron—kidney cancer	0.0151	0.156	CbGeAlD
Losartan—ALB—Erlotinib—kidney cancer	0.0142	0.0262	CbGbCtD
Losartan—CYP1A2—Pazopanib—kidney cancer	0.0119	0.022	CbGbCtD
Losartan—CYP3A4—Temsirolimus—kidney cancer	0.0118	0.0219	CbGbCtD
Losartan—CYP3A5—Erlotinib—kidney cancer	0.0114	0.021	CbGbCtD
Losartan—CYP2C9—Capecitabine—kidney cancer	0.0112	0.0206	CbGbCtD
Losartan—CYP2C8—Erlotinib—kidney cancer	0.0109	0.0202	CbGbCtD
Losartan—CYP3A5—Paclitaxel—kidney cancer	0.0104	0.0193	CbGbCtD
Losartan—SLC2A9—nephron—kidney cancer	0.0104	0.107	CbGeAlD
Losartan—ABCB1—Pazopanib—kidney cancer	0.0104	0.0192	CbGbCtD
Losartan—CYP2C8—Paclitaxel—kidney cancer	0.01	0.0185	CbGbCtD
Losartan—ABCB1—Dactinomycin—kidney cancer	0.00949	0.0176	CbGbCtD
Losartan—CYP3A5—Sorafenib—kidney cancer	0.00925	0.0171	CbGbCtD
Losartan—CYP3A5—Vincristine—kidney cancer	0.00898	0.0166	CbGbCtD
Losartan—CYP2C8—Sorafenib—kidney cancer	0.00889	0.0165	CbGbCtD
Losartan—CYP1A2—Erlotinib—kidney cancer	0.00847	0.0157	CbGbCtD
Losartan—ACE—renal artery—kidney cancer	0.0084	0.0866	CbGeAlD
Losartan—ABCB1—Gemcitabine—kidney cancer	0.0075	0.0139	CbGbCtD
Losartan—CYP3A5—Sunitinib—kidney cancer	0.00749	0.0139	CbGbCtD
Losartan—CYP2C19—Sorafenib—kidney cancer	0.00746	0.0138	CbGbCtD
Losartan—ABCB1—Erlotinib—kidney cancer	0.0074	0.0137	CbGbCtD
Losartan—CYP2C9—Paclitaxel—kidney cancer	0.00698	0.0129	CbGbCtD
Losartan—CYP1A2—Sorafenib—kidney cancer	0.00688	0.0127	CbGbCtD
Losartan—ABCB1—Paclitaxel—kidney cancer	0.00678	0.0125	CbGbCtD
Losartan—CYP3A4—Pazopanib—kidney cancer	0.00622	0.0115	CbGbCtD
Losartan—CYP2C9—Sorafenib—kidney cancer	0.0062	0.0115	CbGbCtD
Losartan—ABCB1—Sorafenib—kidney cancer	0.00602	0.0111	CbGbCtD
Losartan—ABCB1—Vinblastine—kidney cancer	0.00594	0.011	CbGbCtD
Losartan—ABCB1—Vincristine—kidney cancer	0.00584	0.0108	CbGbCtD
Losartan—ABCB1—Sunitinib—kidney cancer	0.00488	0.00903	CbGbCtD
Losartan—CYP3A4—Erlotinib—kidney cancer	0.00444	0.00821	CbGbCtD
Losartan—CYP3A4—Paclitaxel—kidney cancer	0.00406	0.00751	CbGbCtD
Losartan—AGTR1—nephron—kidney cancer	0.00398	0.041	CbGeAlD
Losartan—UGT1A1—urine—kidney cancer	0.00366	0.0377	CbGeAlD
Losartan—ABCB1—Doxorubicin—kidney cancer	0.00365	0.00676	CbGbCtD
Losartan—CYP3A4—Sorafenib—kidney cancer	0.00361	0.00667	CbGbCtD
Losartan—CYP3A4—Vinblastine—kidney cancer	0.00356	0.00659	CbGbCtD
Losartan—CYP3A4—Vincristine—kidney cancer	0.0035	0.00648	CbGbCtD
Losartan—SLC22A12—nephron tubule—kidney cancer	0.00326	0.0336	CbGeAlD
Losartan—SLC22A12—renal system—kidney cancer	0.00297	0.0306	CbGeAlD
Losartan—ACE—nephron—kidney cancer	0.00294	0.0303	CbGeAlD
Losartan—CYP3A4—Sunitinib—kidney cancer	0.00292	0.00541	CbGbCtD
Losartan—SLC22A12—kidney—kidney cancer	0.00287	0.0295	CbGeAlD
Losartan—SLC22A12—cortex of kidney—kidney cancer	0.00279	0.0288	CbGeAlD
Losartan—UGT1A10—renal system—kidney cancer	0.0026	0.0268	CbGeAlD
Losartan—UGT1A10—kidney—kidney cancer	0.00251	0.0259	CbGeAlD
Losartan—ACE—urine—kidney cancer	0.00236	0.0243	CbGeAlD
Losartan—SLC2A9—nephron tubule—kidney cancer	0.00224	0.0231	CbGeAlD
Losartan—CYP3A4—Doxorubicin—kidney cancer	0.00219	0.00405	CbGbCtD
Losartan—SLC2A9—renal system—kidney cancer	0.00204	0.021	CbGeAlD
Losartan—CYP2C19—urine—kidney cancer	0.00198	0.0204	CbGeAlD
Losartan—SLC2A9—kidney—kidney cancer	0.00197	0.0203	CbGeAlD
Losartan—SLC2A9—cortex of kidney—kidney cancer	0.00192	0.0198	CbGeAlD
Losartan—CYP1A2—urine—kidney cancer	0.00162	0.0167	CbGeAlD
Losartan—Irbesartan—JUN—kidney cancer	0.00162	0.529	CrCbGaD
Losartan—CYP2C9—urine—kidney cancer	0.00154	0.0158	CbGeAlD
Losartan—CYP3A4—urine—kidney cancer	0.00117	0.0121	CbGeAlD
Losartan—SLC22A6—nephron tubule—kidney cancer	0.00106	0.011	CbGeAlD
Losartan—UGT2B7—renal system—kidney cancer	0.00105	0.0108	CbGeAlD
Losartan—UGT2B7—kidney—kidney cancer	0.00102	0.0105	CbGeAlD
Losartan—SLC22A6—cortex of kidney—kidney cancer	0.00091	0.00938	CbGeAlD
Losartan—UGT1A1—renal system—kidney cancer	0.000895	0.00922	CbGeAlD
Losartan—UGT1A1—kidney—kidney cancer	0.000865	0.00891	CbGeAlD
Losartan—AGTR1—nephron tubule—kidney cancer	0.000859	0.00885	CbGeAlD
Losartan—AGTR1—renal system—kidney cancer	0.000781	0.00805	CbGeAlD
Losartan—AGTR1—kidney—kidney cancer	0.000755	0.00778	CbGeAlD
Losartan—SLCO1B1—renal system—kidney cancer	0.000744	0.00767	CbGeAlD
Losartan—AGTR1—cortex of kidney—kidney cancer	0.000735	0.00758	CbGeAlD
Losartan—SLCO1B1—kidney—kidney cancer	0.00072	0.00742	CbGeAlD
Losartan—AGTR1—cardiac atrium—kidney cancer	0.000699	0.00721	CbGeAlD
Losartan—ACE—nephron tubule—kidney cancer	0.000634	0.00654	CbGeAlD
Losartan—ACE—renal system—kidney cancer	0.000577	0.00594	CbGeAlD
Losartan—ACE—kidney—kidney cancer	0.000557	0.00574	CbGeAlD
Losartan—ACE—cortex of kidney—kidney cancer	0.000543	0.00559	CbGeAlD
Losartan—ACE—gonad—kidney cancer	0.000517	0.00533	CbGeAlD
Losartan—ACE—cardiac atrium—kidney cancer	0.000516	0.00532	CbGeAlD
Losartan—Candesartan—PTGS1—kidney cancer	0.000466	0.153	CrCbGaD
Losartan—Irbesartan—PTGS1—kidney cancer	0.000466	0.153	CrCbGaD
Losartan—CYP2C8—renal system—kidney cancer	0.000423	0.00436	CbGeAlD
Losartan—CYP3A5—nephron tubule—kidney cancer	0.00042	0.00433	CbGeAlD
Losartan—CYP2C8—kidney—kidney cancer	0.000409	0.00422	CbGeAlD
Losartan—CYP1A2—renal system—kidney cancer	0.000396	0.00408	CbGeAlD
Losartan—CYP3A5—renal system—kidney cancer	0.000382	0.00394	CbGeAlD
Losartan—CYP3A5—kidney—kidney cancer	0.000369	0.00381	CbGeAlD
Losartan—CYP3A5—cortex of kidney—kidney cancer	0.00036	0.00371	CbGeAlD
Losartan—CYP3A4—renal system—kidney cancer	0.000287	0.00295	CbGeAlD
Losartan—Telmisartan—ABCB1—kidney cancer	0.000281	0.092	CrCbGaD
Losartan—CYP3A4—kidney—kidney cancer	0.000277	0.00286	CbGeAlD
Losartan—Candesartan—ABCB1—kidney cancer	0.000226	0.0741	CrCbGaD
Losartan—ABCB1—nephron tubule—kidney cancer	0.000223	0.0023	CbGeAlD
Losartan—ABCB1—renal system—kidney cancer	0.000203	0.00209	CbGeAlD
Losartan—ABCB1—kidney—kidney cancer	0.000196	0.00202	CbGeAlD
Losartan—ABCB1—cortex of kidney—kidney cancer	0.000191	0.00197	CbGeAlD
Losartan—ABCB1—gonad—kidney cancer	0.000182	0.00188	CbGeAlD
Losartan—Nausea—Everolimus—kidney cancer	9.95e-05	0.000595	CcSEcCtD
Losartan—Diarrhoea—Sorafenib—kidney cancer	9.95e-05	0.000595	CcSEcCtD
Losartan—Pruritus—Sunitinib—kidney cancer	9.9e-05	0.000592	CcSEcCtD
Losartan—Angiopathy—Capecitabine—kidney cancer	9.85e-05	0.000589	CcSEcCtD
Losartan—Myalgia—Paclitaxel—kidney cancer	9.81e-05	0.000586	CcSEcCtD
Losartan—Chest pain—Paclitaxel—kidney cancer	9.81e-05	0.000586	CcSEcCtD
Losartan—Arthralgia—Paclitaxel—kidney cancer	9.81e-05	0.000586	CcSEcCtD
Losartan—Anxiety—Paclitaxel—kidney cancer	9.77e-05	0.000584	CcSEcCtD
Losartan—Face oedema—Doxorubicin—kidney cancer	9.77e-05	0.000584	CcSEcCtD
Losartan—Decreased appetite—Gemcitabine—kidney cancer	9.76e-05	0.000584	CcSEcCtD
Losartan—Hypersensitivity—Dactinomycin—kidney cancer	9.76e-05	0.000584	CcSEcCtD
Losartan—Arrhythmia—Capecitabine—kidney cancer	9.7e-05	0.00058	CcSEcCtD
Losartan—Discomfort—Paclitaxel—kidney cancer	9.69e-05	0.000579	CcSEcCtD
Losartan—Fatigue—Gemcitabine—kidney cancer	9.68e-05	0.000579	CcSEcCtD
Losartan—Gastrointestinal pain—Vincristine—kidney cancer	9.68e-05	0.000579	CcSEcCtD
Losartan—Dizziness—Sorafenib—kidney cancer	9.62e-05	0.000575	CcSEcCtD
Losartan—Pain—Gemcitabine—kidney cancer	9.6e-05	0.000574	CcSEcCtD
Losartan—Constipation—Gemcitabine—kidney cancer	9.6e-05	0.000574	CcSEcCtD
Losartan—Nausea—Erlotinib—kidney cancer	9.6e-05	0.000574	CcSEcCtD
Losartan—Alopecia—Capecitabine—kidney cancer	9.59e-05	0.000574	CcSEcCtD
Losartan—Dry mouth—Paclitaxel—kidney cancer	9.59e-05	0.000574	CcSEcCtD
Losartan—Diarrhoea—Sunitinib—kidney cancer	9.57e-05	0.000573	CcSEcCtD
Losartan—Ataxia—Doxorubicin—kidney cancer	9.51e-05	0.000569	CcSEcCtD
Losartan—Asthenia—Dactinomycin—kidney cancer	9.5e-05	0.000568	CcSEcCtD
Losartan—Confusional state—Paclitaxel—kidney cancer	9.48e-05	0.000567	CcSEcCtD
Losartan—Blood creatinine increased—Doxorubicin—kidney cancer	9.48e-05	0.000567	CcSEcCtD
Losartan—Erythema—Capecitabine—kidney cancer	9.45e-05	0.000565	CcSEcCtD
Losartan—Oedema—Paclitaxel—kidney cancer	9.4e-05	0.000562	CcSEcCtD
Losartan—Anaphylactic shock—Paclitaxel—kidney cancer	9.4e-05	0.000562	CcSEcCtD
Losartan—Abdominal pain—Vincristine—kidney cancer	9.36e-05	0.00056	CcSEcCtD
Losartan—Body temperature increased—Vincristine—kidney cancer	9.36e-05	0.00056	CcSEcCtD
Losartan—Infection—Paclitaxel—kidney cancer	9.34e-05	0.000559	CcSEcCtD
Losartan—Flatulence—Capecitabine—kidney cancer	9.31e-05	0.000557	CcSEcCtD
Losartan—Dry skin—Doxorubicin—kidney cancer	9.27e-05	0.000555	CcSEcCtD
Losartan—Dysgeusia—Capecitabine—kidney cancer	9.26e-05	0.000554	CcSEcCtD
Losartan—Dizziness—Sunitinib—kidney cancer	9.25e-05	0.000553	CcSEcCtD
Losartan—Feeling abnormal—Gemcitabine—kidney cancer	9.25e-05	0.000553	CcSEcCtD
Losartan—Shock—Paclitaxel—kidney cancer	9.25e-05	0.000553	CcSEcCtD
Losartan—Vomiting—Sorafenib—kidney cancer	9.25e-05	0.000553	CcSEcCtD
Losartan—Orthostatic hypotension—Doxorubicin—kidney cancer	9.24e-05	0.000553	CcSEcCtD
Losartan—Nervous system disorder—Paclitaxel—kidney cancer	9.22e-05	0.000551	CcSEcCtD
Losartan—Thrombocytopenia—Paclitaxel—kidney cancer	9.2e-05	0.00055	CcSEcCtD
Losartan—Tachycardia—Paclitaxel—kidney cancer	9.17e-05	0.000549	CcSEcCtD
Losartan—Rash—Sorafenib—kidney cancer	9.17e-05	0.000548	CcSEcCtD
Losartan—Dermatitis—Sorafenib—kidney cancer	9.16e-05	0.000548	CcSEcCtD
Losartan—Back pain—Capecitabine—kidney cancer	9.14e-05	0.000547	CcSEcCtD
Losartan—Breast disorder—Doxorubicin—kidney cancer	9.14e-05	0.000547	CcSEcCtD
Losartan—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	9.11e-05	0.000545	CcSEcCtD
Losartan—Headache—Sorafenib—kidney cancer	9.11e-05	0.000545	CcSEcCtD
Losartan—Muscle spasms—Capecitabine—kidney cancer	9.09e-05	0.000544	CcSEcCtD
Losartan—Hyperhidrosis—Paclitaxel—kidney cancer	9.09e-05	0.000544	CcSEcCtD
Losartan—Diarrhoea—Dactinomycin—kidney cancer	9.06e-05	0.000542	CcSEcCtD
Losartan—Anorexia—Paclitaxel—kidney cancer	8.96e-05	0.000536	CcSEcCtD
Losartan—Gastritis—Doxorubicin—kidney cancer	8.95e-05	0.000536	CcSEcCtD
Losartan—Muscular weakness—Doxorubicin—kidney cancer	8.92e-05	0.000534	CcSEcCtD
Losartan—Vision blurred—Capecitabine—kidney cancer	8.91e-05	0.000533	CcSEcCtD
Losartan—Vomiting—Sunitinib—kidney cancer	8.9e-05	0.000532	CcSEcCtD
Losartan—Body temperature increased—Gemcitabine—kidney cancer	8.88e-05	0.000531	CcSEcCtD
Losartan—Tremor—Capecitabine—kidney cancer	8.86e-05	0.00053	CcSEcCtD
Losartan—Rash—Sunitinib—kidney cancer	8.82e-05	0.000528	CcSEcCtD
Losartan—Dermatitis—Sunitinib—kidney cancer	8.81e-05	0.000527	CcSEcCtD
Losartan—Hypotension—Paclitaxel—kidney cancer	8.78e-05	0.000525	CcSEcCtD
Losartan—Ill-defined disorder—Capecitabine—kidney cancer	8.77e-05	0.000525	CcSEcCtD
Losartan—Headache—Sunitinib—kidney cancer	8.77e-05	0.000524	CcSEcCtD
Losartan—Influenza—Doxorubicin—kidney cancer	8.74e-05	0.000523	CcSEcCtD
Losartan—Anaemia—Capecitabine—kidney cancer	8.74e-05	0.000523	CcSEcCtD
Losartan—Hypersensitivity—Vincristine—kidney cancer	8.72e-05	0.000522	CcSEcCtD
Losartan—Eosinophilia—Doxorubicin—kidney cancer	8.66e-05	0.000518	CcSEcCtD
Losartan—Nausea—Sorafenib—kidney cancer	8.64e-05	0.000517	CcSEcCtD
Losartan—Pancreatitis—Doxorubicin—kidney cancer	8.57e-05	0.000513	CcSEcCtD
Losartan—Musculoskeletal discomfort—Paclitaxel—kidney cancer	8.56e-05	0.000512	CcSEcCtD
Losartan—Malaise—Capecitabine—kidney cancer	8.52e-05	0.00051	CcSEcCtD
Losartan—Angina pectoris—Doxorubicin—kidney cancer	8.52e-05	0.000509	CcSEcCtD
Losartan—Insomnia—Paclitaxel—kidney cancer	8.5e-05	0.000509	CcSEcCtD
Losartan—Vertigo—Capecitabine—kidney cancer	8.49e-05	0.000508	CcSEcCtD
Losartan—Asthenia—Vincristine—kidney cancer	8.49e-05	0.000508	CcSEcCtD
Losartan—Syncope—Capecitabine—kidney cancer	8.48e-05	0.000507	CcSEcCtD
Losartan—Leukopenia—Capecitabine—kidney cancer	8.46e-05	0.000506	CcSEcCtD
Losartan—Paraesthesia—Paclitaxel—kidney cancer	8.44e-05	0.000505	CcSEcCtD
Losartan—Vomiting—Dactinomycin—kidney cancer	8.42e-05	0.000504	CcSEcCtD
Losartan—Bronchitis—Doxorubicin—kidney cancer	8.41e-05	0.000503	CcSEcCtD
Losartan—Dyspnoea—Paclitaxel—kidney cancer	8.38e-05	0.000501	CcSEcCtD
Losartan—Somnolence—Paclitaxel—kidney cancer	8.36e-05	0.0005	CcSEcCtD
Losartan—Palpitations—Capecitabine—kidney cancer	8.35e-05	0.0005	CcSEcCtD
Losartan—Rash—Dactinomycin—kidney cancer	8.35e-05	0.0005	CcSEcCtD
Losartan—Nausea—Sunitinib—kidney cancer	8.31e-05	0.000497	CcSEcCtD
Losartan—Loss of consciousness—Capecitabine—kidney cancer	8.31e-05	0.000497	CcSEcCtD
Losartan—Dyspepsia—Paclitaxel—kidney cancer	8.27e-05	0.000495	CcSEcCtD
Losartan—Cough—Capecitabine—kidney cancer	8.25e-05	0.000493	CcSEcCtD
Losartan—Decreased appetite—Paclitaxel—kidney cancer	8.17e-05	0.000489	CcSEcCtD
Losartan—Upper respiratory tract infection—Doxorubicin—kidney cancer	8.13e-05	0.000486	CcSEcCtD
Losartan—Fatigue—Paclitaxel—kidney cancer	8.1e-05	0.000485	CcSEcCtD
Losartan—Diarrhoea—Vincristine—kidney cancer	8.1e-05	0.000484	CcSEcCtD
Losartan—Pollakiuria—Doxorubicin—kidney cancer	8.08e-05	0.000483	CcSEcCtD
Losartan—Asthenia—Gemcitabine—kidney cancer	8.06e-05	0.000482	CcSEcCtD
Losartan—Myalgia—Capecitabine—kidney cancer	8.05e-05	0.000481	CcSEcCtD
Losartan—Chest pain—Capecitabine—kidney cancer	8.05e-05	0.000481	CcSEcCtD
Losartan—Arthralgia—Capecitabine—kidney cancer	8.05e-05	0.000481	CcSEcCtD
Losartan—Pain—Paclitaxel—kidney cancer	8.04e-05	0.000481	CcSEcCtD
Losartan—Constipation—Paclitaxel—kidney cancer	8.04e-05	0.000481	CcSEcCtD
Losartan—Anxiety—Capecitabine—kidney cancer	8.02e-05	0.00048	CcSEcCtD
Losartan—Photosensitivity reaction—Doxorubicin—kidney cancer	7.98e-05	0.000477	CcSEcCtD
Losartan—Weight increased—Doxorubicin—kidney cancer	7.96e-05	0.000476	CcSEcCtD
Losartan—Discomfort—Capecitabine—kidney cancer	7.95e-05	0.000476	CcSEcCtD
Losartan—Pruritus—Gemcitabine—kidney cancer	7.94e-05	0.000475	CcSEcCtD
Losartan—Hyperglycaemia—Doxorubicin—kidney cancer	7.89e-05	0.000472	CcSEcCtD
Losartan—Dry mouth—Capecitabine—kidney cancer	7.87e-05	0.000471	CcSEcCtD
Losartan—Nausea—Dactinomycin—kidney cancer	7.87e-05	0.000471	CcSEcCtD
Losartan—Pneumonia—Doxorubicin—kidney cancer	7.84e-05	0.000469	CcSEcCtD
Losartan—Dizziness—Vincristine—kidney cancer	7.83e-05	0.000468	CcSEcCtD
Losartan—Confusional state—Capecitabine—kidney cancer	7.78e-05	0.000465	CcSEcCtD
Losartan—Feeling abnormal—Paclitaxel—kidney cancer	7.75e-05	0.000463	CcSEcCtD
Losartan—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	7.73e-05	0.000462	CcSEcCtD
Losartan—Oedema—Capecitabine—kidney cancer	7.71e-05	0.000461	CcSEcCtD
Losartan—Gastrointestinal pain—Paclitaxel—kidney cancer	7.69e-05	0.00046	CcSEcCtD
Losartan—Diarrhoea—Gemcitabine—kidney cancer	7.68e-05	0.000459	CcSEcCtD
Losartan—Renal failure—Doxorubicin—kidney cancer	7.66e-05	0.000458	CcSEcCtD
Losartan—Infection—Capecitabine—kidney cancer	7.66e-05	0.000458	CcSEcCtD
Losartan—Neuropathy peripheral—Doxorubicin—kidney cancer	7.64e-05	0.000457	CcSEcCtD
Losartan—Jaundice—Doxorubicin—kidney cancer	7.6e-05	0.000455	CcSEcCtD
Losartan—Shock—Capecitabine—kidney cancer	7.59e-05	0.000454	CcSEcCtD
Losartan—Conjunctivitis—Doxorubicin—kidney cancer	7.58e-05	0.000453	CcSEcCtD
Losartan—Urinary tract infection—Doxorubicin—kidney cancer	7.58e-05	0.000453	CcSEcCtD
Losartan—Nervous system disorder—Capecitabine—kidney cancer	7.56e-05	0.000452	CcSEcCtD
Losartan—Thrombocytopenia—Capecitabine—kidney cancer	7.55e-05	0.000452	CcSEcCtD
Losartan—Tachycardia—Capecitabine—kidney cancer	7.53e-05	0.00045	CcSEcCtD
Losartan—Vomiting—Vincristine—kidney cancer	7.52e-05	0.00045	CcSEcCtD
Losartan—Sweating—Doxorubicin—kidney cancer	7.47e-05	0.000447	CcSEcCtD
Losartan—Urticaria—Paclitaxel—kidney cancer	7.47e-05	0.000447	CcSEcCtD
Losartan—Rash—Vincristine—kidney cancer	7.46e-05	0.000446	CcSEcCtD
Losartan—Hyperhidrosis—Capecitabine—kidney cancer	7.46e-05	0.000446	CcSEcCtD
Losartan—Dermatitis—Vincristine—kidney cancer	7.46e-05	0.000446	CcSEcCtD
Losartan—Abdominal pain—Paclitaxel—kidney cancer	7.43e-05	0.000444	CcSEcCtD
Losartan—Body temperature increased—Paclitaxel—kidney cancer	7.43e-05	0.000444	CcSEcCtD
Losartan—Headache—Vincristine—kidney cancer	7.41e-05	0.000443	CcSEcCtD
Losartan—Epistaxis—Doxorubicin—kidney cancer	7.35e-05	0.00044	CcSEcCtD
Losartan—Anorexia—Capecitabine—kidney cancer	7.35e-05	0.00044	CcSEcCtD
Losartan—Sinusitis—Doxorubicin—kidney cancer	7.31e-05	0.000437	CcSEcCtD
Losartan—Agranulocytosis—Doxorubicin—kidney cancer	7.28e-05	0.000435	CcSEcCtD
Losartan—Hypotension—Capecitabine—kidney cancer	7.21e-05	0.000431	CcSEcCtD
Losartan—Vomiting—Gemcitabine—kidney cancer	7.14e-05	0.000427	CcSEcCtD
Losartan—Rash—Gemcitabine—kidney cancer	7.08e-05	0.000423	CcSEcCtD
Losartan—Dermatitis—Gemcitabine—kidney cancer	7.07e-05	0.000423	CcSEcCtD
Losartan—Headache—Gemcitabine—kidney cancer	7.03e-05	0.000421	CcSEcCtD
Losartan—Nausea—Vincristine—kidney cancer	7.03e-05	0.00042	CcSEcCtD
Losartan—Musculoskeletal discomfort—Capecitabine—kidney cancer	7.03e-05	0.00042	CcSEcCtD
Losartan—Rhinitis—Doxorubicin—kidney cancer	7.02e-05	0.00042	CcSEcCtD
Losartan—Hepatitis—Doxorubicin—kidney cancer	7e-05	0.000419	CcSEcCtD
Losartan—Insomnia—Capecitabine—kidney cancer	6.98e-05	0.000417	CcSEcCtD
Losartan—Hypoaesthesia—Doxorubicin—kidney cancer	6.96e-05	0.000417	CcSEcCtD
Losartan—Pharyngitis—Doxorubicin—kidney cancer	6.95e-05	0.000415	CcSEcCtD
Losartan—Paraesthesia—Capecitabine—kidney cancer	6.93e-05	0.000414	CcSEcCtD
Losartan—Hypersensitivity—Paclitaxel—kidney cancer	6.93e-05	0.000414	CcSEcCtD
Losartan—Dyspnoea—Capecitabine—kidney cancer	6.88e-05	0.000411	CcSEcCtD
Losartan—Dyspepsia—Capecitabine—kidney cancer	6.79e-05	0.000406	CcSEcCtD
Losartan—Asthenia—Paclitaxel—kidney cancer	6.74e-05	0.000403	CcSEcCtD
Losartan—Decreased appetite—Capecitabine—kidney cancer	6.71e-05	0.000401	CcSEcCtD
Losartan—Nausea—Gemcitabine—kidney cancer	6.67e-05	0.000399	CcSEcCtD
Losartan—Fatigue—Capecitabine—kidney cancer	6.65e-05	0.000398	CcSEcCtD
Losartan—Pruritus—Paclitaxel—kidney cancer	6.65e-05	0.000398	CcSEcCtD
Losartan—Erythema multiforme—Doxorubicin—kidney cancer	6.62e-05	0.000396	CcSEcCtD
Losartan—Pain—Capecitabine—kidney cancer	6.6e-05	0.000395	CcSEcCtD
Losartan—Constipation—Capecitabine—kidney cancer	6.6e-05	0.000395	CcSEcCtD
Losartan—Tinnitus—Doxorubicin—kidney cancer	6.53e-05	0.00039	CcSEcCtD
Losartan—Flushing—Doxorubicin—kidney cancer	6.5e-05	0.000389	CcSEcCtD
Losartan—Diarrhoea—Paclitaxel—kidney cancer	6.43e-05	0.000385	CcSEcCtD
Losartan—Feeling abnormal—Capecitabine—kidney cancer	6.36e-05	0.00038	CcSEcCtD
Losartan—Angiopathy—Doxorubicin—kidney cancer	6.35e-05	0.00038	CcSEcCtD
Losartan—Gastrointestinal pain—Capecitabine—kidney cancer	6.31e-05	0.000377	CcSEcCtD
Losartan—Arrhythmia—Doxorubicin—kidney cancer	6.25e-05	0.000374	CcSEcCtD
Losartan—Dizziness—Paclitaxel—kidney cancer	6.22e-05	0.000372	CcSEcCtD
Losartan—Alopecia—Doxorubicin—kidney cancer	6.18e-05	0.00037	CcSEcCtD
Losartan—Urticaria—Capecitabine—kidney cancer	6.13e-05	0.000367	CcSEcCtD
Losartan—Body temperature increased—Capecitabine—kidney cancer	6.1e-05	0.000365	CcSEcCtD
Losartan—Abdominal pain—Capecitabine—kidney cancer	6.1e-05	0.000365	CcSEcCtD
Losartan—Erythema—Doxorubicin—kidney cancer	6.09e-05	0.000364	CcSEcCtD
Losartan—Flatulence—Doxorubicin—kidney cancer	6e-05	0.000359	CcSEcCtD
Losartan—Tension—Doxorubicin—kidney cancer	5.98e-05	0.000358	CcSEcCtD
Losartan—Vomiting—Paclitaxel—kidney cancer	5.98e-05	0.000357	CcSEcCtD
Losartan—Dysgeusia—Doxorubicin—kidney cancer	5.97e-05	0.000357	CcSEcCtD
Losartan—Rash—Paclitaxel—kidney cancer	5.93e-05	0.000354	CcSEcCtD
Losartan—Dermatitis—Paclitaxel—kidney cancer	5.92e-05	0.000354	CcSEcCtD
Losartan—Nervousness—Doxorubicin—kidney cancer	5.92e-05	0.000354	CcSEcCtD
Losartan—Back pain—Doxorubicin—kidney cancer	5.89e-05	0.000352	CcSEcCtD
Losartan—Headache—Paclitaxel—kidney cancer	5.89e-05	0.000352	CcSEcCtD
Losartan—Muscle spasms—Doxorubicin—kidney cancer	5.86e-05	0.00035	CcSEcCtD
Losartan—Vision blurred—Doxorubicin—kidney cancer	5.74e-05	0.000343	CcSEcCtD
Losartan—Hypersensitivity—Capecitabine—kidney cancer	5.68e-05	0.00034	CcSEcCtD
Losartan—Ill-defined disorder—Doxorubicin—kidney cancer	5.65e-05	0.000338	CcSEcCtD
Losartan—Anaemia—Doxorubicin—kidney cancer	5.63e-05	0.000337	CcSEcCtD
Losartan—Agitation—Doxorubicin—kidney cancer	5.6e-05	0.000335	CcSEcCtD
Losartan—Nausea—Paclitaxel—kidney cancer	5.58e-05	0.000334	CcSEcCtD
Losartan—Asthenia—Capecitabine—kidney cancer	5.53e-05	0.000331	CcSEcCtD
Losartan—Malaise—Doxorubicin—kidney cancer	5.49e-05	0.000329	CcSEcCtD
Losartan—Vertigo—Doxorubicin—kidney cancer	5.47e-05	0.000327	CcSEcCtD
Losartan—Syncope—Doxorubicin—kidney cancer	5.46e-05	0.000327	CcSEcCtD
Losartan—Pruritus—Capecitabine—kidney cancer	5.46e-05	0.000326	CcSEcCtD
Losartan—Leukopenia—Doxorubicin—kidney cancer	5.45e-05	0.000326	CcSEcCtD
Losartan—Palpitations—Doxorubicin—kidney cancer	5.38e-05	0.000322	CcSEcCtD
Losartan—Loss of consciousness—Doxorubicin—kidney cancer	5.35e-05	0.00032	CcSEcCtD
Losartan—Cough—Doxorubicin—kidney cancer	5.32e-05	0.000318	CcSEcCtD
Losartan—Diarrhoea—Capecitabine—kidney cancer	5.28e-05	0.000316	CcSEcCtD
Losartan—Chest pain—Doxorubicin—kidney cancer	5.19e-05	0.00031	CcSEcCtD
Losartan—Myalgia—Doxorubicin—kidney cancer	5.19e-05	0.00031	CcSEcCtD
Losartan—Arthralgia—Doxorubicin—kidney cancer	5.19e-05	0.00031	CcSEcCtD
Losartan—Anxiety—Doxorubicin—kidney cancer	5.17e-05	0.000309	CcSEcCtD
Losartan—Discomfort—Doxorubicin—kidney cancer	5.12e-05	0.000307	CcSEcCtD
Losartan—Dizziness—Capecitabine—kidney cancer	5.1e-05	0.000305	CcSEcCtD
Losartan—Dry mouth—Doxorubicin—kidney cancer	5.07e-05	0.000303	CcSEcCtD
Losartan—Confusional state—Doxorubicin—kidney cancer	5.01e-05	0.0003	CcSEcCtD
Losartan—Anaphylactic shock—Doxorubicin—kidney cancer	4.97e-05	0.000297	CcSEcCtD
Losartan—Oedema—Doxorubicin—kidney cancer	4.97e-05	0.000297	CcSEcCtD
Losartan—Infection—Doxorubicin—kidney cancer	4.94e-05	0.000295	CcSEcCtD
Losartan—Vomiting—Capecitabine—kidney cancer	4.9e-05	0.000293	CcSEcCtD
Losartan—Shock—Doxorubicin—kidney cancer	4.89e-05	0.000293	CcSEcCtD
Losartan—Nervous system disorder—Doxorubicin—kidney cancer	4.88e-05	0.000292	CcSEcCtD
Losartan—Thrombocytopenia—Doxorubicin—kidney cancer	4.87e-05	0.000291	CcSEcCtD
Losartan—Rash—Capecitabine—kidney cancer	4.86e-05	0.000291	CcSEcCtD
Losartan—Dermatitis—Capecitabine—kidney cancer	4.86e-05	0.000291	CcSEcCtD
Losartan—Tachycardia—Doxorubicin—kidney cancer	4.85e-05	0.00029	CcSEcCtD
Losartan—Headache—Capecitabine—kidney cancer	4.83e-05	0.000289	CcSEcCtD
Losartan—Hyperhidrosis—Doxorubicin—kidney cancer	4.81e-05	0.000288	CcSEcCtD
Losartan—Anorexia—Doxorubicin—kidney cancer	4.74e-05	0.000283	CcSEcCtD
Losartan—Hypotension—Doxorubicin—kidney cancer	4.65e-05	0.000278	CcSEcCtD
Losartan—Nausea—Capecitabine—kidney cancer	4.58e-05	0.000274	CcSEcCtD
Losartan—Musculoskeletal discomfort—Doxorubicin—kidney cancer	4.53e-05	0.000271	CcSEcCtD
Losartan—Insomnia—Doxorubicin—kidney cancer	4.5e-05	0.000269	CcSEcCtD
Losartan—Paraesthesia—Doxorubicin—kidney cancer	4.46e-05	0.000267	CcSEcCtD
Losartan—Dyspnoea—Doxorubicin—kidney cancer	4.43e-05	0.000265	CcSEcCtD
Losartan—Somnolence—Doxorubicin—kidney cancer	4.42e-05	0.000264	CcSEcCtD
Losartan—Dyspepsia—Doxorubicin—kidney cancer	4.38e-05	0.000262	CcSEcCtD
Losartan—Decreased appetite—Doxorubicin—kidney cancer	4.32e-05	0.000259	CcSEcCtD
Losartan—Fatigue—Doxorubicin—kidney cancer	4.29e-05	0.000256	CcSEcCtD
Losartan—Pain—Doxorubicin—kidney cancer	4.25e-05	0.000254	CcSEcCtD
Losartan—Constipation—Doxorubicin—kidney cancer	4.25e-05	0.000254	CcSEcCtD
Losartan—Feeling abnormal—Doxorubicin—kidney cancer	4.1e-05	0.000245	CcSEcCtD
Losartan—Gastrointestinal pain—Doxorubicin—kidney cancer	4.07e-05	0.000243	CcSEcCtD
Losartan—Urticaria—Doxorubicin—kidney cancer	3.95e-05	0.000236	CcSEcCtD
Losartan—Body temperature increased—Doxorubicin—kidney cancer	3.93e-05	0.000235	CcSEcCtD
Losartan—Abdominal pain—Doxorubicin—kidney cancer	3.93e-05	0.000235	CcSEcCtD
Losartan—Hypersensitivity—Doxorubicin—kidney cancer	3.66e-05	0.000219	CcSEcCtD
Losartan—Asthenia—Doxorubicin—kidney cancer	3.57e-05	0.000213	CcSEcCtD
Losartan—Pruritus—Doxorubicin—kidney cancer	3.52e-05	0.00021	CcSEcCtD
Losartan—Diarrhoea—Doxorubicin—kidney cancer	3.4e-05	0.000203	CcSEcCtD
Losartan—Dizziness—Doxorubicin—kidney cancer	3.29e-05	0.000197	CcSEcCtD
Losartan—Vomiting—Doxorubicin—kidney cancer	3.16e-05	0.000189	CcSEcCtD
Losartan—Rash—Doxorubicin—kidney cancer	3.14e-05	0.000188	CcSEcCtD
Losartan—Dermatitis—Doxorubicin—kidney cancer	3.13e-05	0.000187	CcSEcCtD
Losartan—Headache—Doxorubicin—kidney cancer	3.12e-05	0.000186	CcSEcCtD
Losartan—Nausea—Doxorubicin—kidney cancer	2.95e-05	0.000177	CcSEcCtD
Losartan—UGT1A1—Metabolism—GSTM1—kidney cancer	8.64e-06	0.000107	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CA9—kidney cancer	8.63e-06	0.000107	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—GSTP1—kidney cancer	8.62e-06	0.000106	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	8.52e-06	0.000105	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ALDH1A1—kidney cancer	8.45e-06	0.000104	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CRABP1—kidney cancer	8.43e-06	0.000104	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—KIT—kidney cancer	8.39e-06	0.000104	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—APC—kidney cancer	8.39e-06	0.000104	CbGpPWpGaD
Losartan—ALB—Metabolism—CRABP1—kidney cancer	8.38e-06	0.000104	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—POMC—kidney cancer	8.33e-06	0.000103	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PPAT—kidney cancer	8.25e-06	0.000102	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GLIPR1—kidney cancer	8.25e-06	0.000102	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GSTT1—kidney cancer	8.25e-06	0.000102	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ACHE—kidney cancer	8.25e-06	0.000102	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—CYP1A1—kidney cancer	8.19e-06	0.000101	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—ABCB1—kidney cancer	8.16e-06	0.000101	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PGK1—kidney cancer	8.11e-06	0.0001	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—SLC5A3—kidney cancer	8.11e-06	0.0001	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CA9—kidney cancer	8.07e-06	9.97e-05	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	8.05e-06	9.94e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—MAPK3—kidney cancer	8.03e-06	9.92e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—POMC—kidney cancer	7.98e-06	9.86e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—LDHB—kidney cancer	7.95e-06	9.82e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—GSTM1—kidney cancer	7.92e-06	9.79e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.88e-06	9.74e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—BRAF—kidney cancer	7.88e-06	9.74e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ITPR2—kidney cancer	7.83e-06	9.68e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—SCARB1—kidney cancer	7.81e-06	9.65e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—ITPR2—kidney cancer	7.79e-06	9.63e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PTGS1—kidney cancer	7.73e-06	9.55e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—FH—kidney cancer	7.67e-06	9.48e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—APRT—kidney cancer	7.67e-06	9.48e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—MAPK1—kidney cancer	7.64e-06	9.44e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PSMD7—kidney cancer	7.58e-06	9.37e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CRABP1—kidney cancer	7.52e-06	9.29e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—POMC—kidney cancer	7.52e-06	9.29e-05	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	7.51e-06	9.28e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—CYP1A1—kidney cancer	7.51e-06	9.28e-05	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	7.39e-06	9.14e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CRABP1—kidney cancer	7.34e-06	9.07e-05	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—PIK3CA—kidney cancer	7.3e-06	9.02e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.22e-06	8.92e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—KRAS—kidney cancer	7.22e-06	8.92e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GPC3—kidney cancer	7.22e-06	8.92e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—BCHE—kidney cancer	7.19e-06	8.88e-05	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.18e-06	8.87e-05	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	7.15e-06	8.84e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GSTT1—kidney cancer	7.14e-06	8.83e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ACHE—kidney cancer	7.14e-06	8.83e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—GSTT1—kidney cancer	7.1e-06	8.78e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—ACHE—kidney cancer	7.1e-06	8.78e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—SLC5A5—kidney cancer	7.1e-06	8.77e-05	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PTGS2—kidney cancer	7.05e-06	8.71e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CA2—kidney cancer	7.02e-06	8.67e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ITPR2—kidney cancer	6.99e-06	8.64e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CA9—kidney cancer	6.89e-06	8.52e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CRABP1—kidney cancer	6.86e-06	8.47e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—SLC2A1—kidney cancer	6.85e-06	8.47e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ALAD—kidney cancer	6.84e-06	8.45e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ITPR2—kidney cancer	6.82e-06	8.43e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—SCARB1—kidney cancer	6.76e-06	8.36e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	6.74e-06	8.32e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—SCARB1—kidney cancer	6.72e-06	8.31e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PTGS1—kidney cancer	6.69e-06	8.27e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ST3GAL2—kidney cancer	6.68e-06	8.25e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PTGS1—kidney cancer	6.66e-06	8.22e-05	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PTGS2—kidney cancer	6.64e-06	8.21e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—PIK3CA—kidney cancer	6.63e-06	8.19e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—RAF1—kidney cancer	6.58e-06	8.13e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PSMD7—kidney cancer	6.56e-06	8.11e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—RELA—kidney cancer	6.55e-06	8.1e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PSMD7—kidney cancer	6.53e-06	8.07e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ALDH1A1—kidney cancer	6.53e-06	8.06e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—ERBB2—kidney cancer	6.51e-06	8.05e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—RAF1—kidney cancer	6.5e-06	8.04e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.45e-06	7.97e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MTOR—kidney cancer	6.43e-06	7.94e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ACHE—kidney cancer	6.38e-06	7.88e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GSTT1—kidney cancer	6.38e-06	7.88e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ITPR2—kidney cancer	6.38e-06	7.88e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SLC5A3—kidney cancer	6.26e-06	7.73e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PGK1—kidney cancer	6.26e-06	7.73e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GSTT1—kidney cancer	6.22e-06	7.69e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ACHE—kidney cancer	6.22e-06	7.69e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—BCHE—kidney cancer	6.22e-06	7.69e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—BCHE—kidney cancer	6.19e-06	7.65e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.17e-06	7.62e-05	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PTEN—kidney cancer	6.15e-06	7.6e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—SLC5A5—kidney cancer	6.15e-06	7.6e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—LDHB—kidney cancer	6.14e-06	7.58e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—SLC5A5—kidney cancer	6.11e-06	7.55e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—POMC—kidney cancer	6.11e-06	7.55e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—SCARB1—kidney cancer	6.04e-06	7.46e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CDKN1B—kidney cancer	6.03e-06	7.45e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PTGS2—kidney cancer	6e-06	7.41e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PTGS1—kidney cancer	5.98e-06	7.38e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—SLC2A1—kidney cancer	5.94e-06	7.34e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—SLC2A1—kidney cancer	5.9e-06	7.29e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IL2—kidney cancer	5.9e-06	7.29e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—SCARB1—kidney cancer	5.89e-06	7.28e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.88e-06	7.26e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CRABP1—kidney cancer	5.86e-06	7.24e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PSMD7—kidney cancer	5.86e-06	7.24e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PTGS1—kidney cancer	5.83e-06	7.21e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—IL2—kidney cancer	5.83e-06	7.21e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GSTT1—kidney cancer	5.81e-06	7.18e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ACHE—kidney cancer	5.81e-06	7.18e-05	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PTEN—kidney cancer	5.79e-06	7.16e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.76e-06	7.12e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CCND1—kidney cancer	5.75e-06	7.11e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—JUN—kidney cancer	5.74e-06	7.09e-05	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.73e-06	7.08e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PSMD7—kidney cancer	5.72e-06	7.07e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GSTP1—kidney cancer	5.72e-06	7.06e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CTNNB1—kidney cancer	5.7e-06	7.04e-05	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	5.63e-06	6.96e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—POMC—kidney cancer	5.6e-06	6.92e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—BCHE—kidney cancer	5.55e-06	6.86e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PTEN—kidney cancer	5.55e-06	6.86e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—SCARB1—kidney cancer	5.5e-06	6.8e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—SLC5A5—kidney cancer	5.49e-06	6.78e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ITPR2—kidney cancer	5.45e-06	6.73e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PTGS1—kidney cancer	5.45e-06	6.73e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—BCHE—kidney cancer	5.42e-06	6.7e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ABCB1—kidney cancer	5.41e-06	6.69e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—SLC5A5—kidney cancer	5.36e-06	6.62e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PSMD7—kidney cancer	5.34e-06	6.6e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CA9—kidney cancer	5.32e-06	6.57e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—SLC2A1—kidney cancer	5.3e-06	6.55e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GSTM1—kidney cancer	5.25e-06	6.49e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PTEN—kidney cancer	5.23e-06	6.46e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—SLC2A1—kidney cancer	5.17e-06	6.39e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.14e-06	6.35e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—BCHE—kidney cancer	5.06e-06	6.26e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.02e-06	6.21e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.02e-06	6.21e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—VEGFA—kidney cancer	5.02e-06	6.2e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—SLC5A5—kidney cancer	5e-06	6.18e-05	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.99e-06	6.17e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CYP1A1—kidney cancer	4.98e-06	6.15e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GSTT1—kidney cancer	4.97e-06	6.14e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ACHE—kidney cancer	4.97e-06	6.14e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—VEGFA—kidney cancer	4.96e-06	6.12e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GSTP1—kidney cancer	4.95e-06	6.12e-05	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	4.93e-06	6.1e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—GSTP1—kidney cancer	4.92e-06	6.08e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PTGS2—kidney cancer	4.87e-06	6.02e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—SLC2A1—kidney cancer	4.83e-06	5.97e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MAPK3—kidney cancer	4.74e-06	5.86e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—SCARB1—kidney cancer	4.7e-06	5.81e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.69e-06	5.79e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—MAPK3—kidney cancer	4.69e-06	5.79e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ABCB1—kidney cancer	4.69e-06	5.79e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—ABCB1—kidney cancer	4.66e-06	5.76e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PTGS1—kidney cancer	4.66e-06	5.75e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MYC—kidney cancer	4.61e-06	5.7e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PSMD7—kidney cancer	4.57e-06	5.64e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GSTM1—kidney cancer	4.55e-06	5.62e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—GSTM1—kidney cancer	4.52e-06	5.59e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CRABP1—kidney cancer	4.52e-06	5.59e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MAPK1—kidney cancer	4.51e-06	5.58e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.48e-06	5.54e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PTGS2—kidney cancer	4.46e-06	5.52e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—MAPK1—kidney cancer	4.46e-06	5.51e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GSTP1—kidney cancer	4.42e-06	5.46e-05	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PIK3CA—kidney cancer	4.34e-06	5.36e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—BCHE—kidney cancer	4.33e-06	5.35e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GSTP1—kidney cancer	4.31e-06	5.33e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CYP1A1—kidney cancer	4.31e-06	5.33e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—CYP1A1—kidney cancer	4.29e-06	5.3e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—SLC5A5—kidney cancer	4.28e-06	5.28e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—KRAS—kidney cancer	4.26e-06	5.27e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PTEN—kidney cancer	4.25e-06	5.25e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—KRAS—kidney cancer	4.21e-06	5.21e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ITPR2—kidney cancer	4.2e-06	5.2e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ABCB1—kidney cancer	4.18e-06	5.17e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—SLC2A1—kidney cancer	4.13e-06	5.1e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.09e-06	5.05e-05	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PIK3CA—kidney cancer	4.09e-06	5.05e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GSTM1—kidney cancer	4.06e-06	5.02e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GSTP1—kidney cancer	4.03e-06	4.98e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.01e-06	4.95e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GSTM1—kidney cancer	3.96e-06	4.9e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PIK3CA—kidney cancer	3.92e-06	4.84e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PTEN—kidney cancer	3.89e-06	4.81e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—PIK3CA—kidney cancer	3.87e-06	4.78e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CYP1A1—kidney cancer	3.85e-06	4.76e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ACHE—kidney cancer	3.83e-06	4.74e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GSTT1—kidney cancer	3.83e-06	4.74e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ABCB1—kidney cancer	3.81e-06	4.71e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TP53—kidney cancer	3.79e-06	4.68e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CYP1A1—kidney cancer	3.76e-06	4.64e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—TP53—kidney cancer	3.74e-06	4.63e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—POMC—kidney cancer	3.71e-06	4.59e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GSTM1—kidney cancer	3.7e-06	4.58e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PIK3CA—kidney cancer	3.69e-06	4.56e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SCARB1—kidney cancer	3.63e-06	4.49e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PTGS1—kidney cancer	3.59e-06	4.44e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.54e-06	4.38e-05	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.52e-06	4.35e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PSMD7—kidney cancer	3.52e-06	4.35e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CYP1A1—kidney cancer	3.51e-06	4.34e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.49e-06	4.32e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GSTP1—kidney cancer	3.44e-06	4.26e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—BCHE—kidney cancer	3.34e-06	4.13e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SLC5A5—kidney cancer	3.3e-06	4.08e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ABCB1—kidney cancer	3.26e-06	4.03e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—POMC—kidney cancer	3.22e-06	3.97e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—POMC—kidney cancer	3.2e-06	3.95e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.19e-06	3.94e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GSTM1—kidney cancer	3.16e-06	3.91e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.16e-06	3.91e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYP1A1—kidney cancer	3e-06	3.71e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PIK3CA—kidney cancer	3e-06	3.7e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PTGS2—kidney cancer	2.96e-06	3.66e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.88e-06	3.56e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—POMC—kidney cancer	2.87e-06	3.55e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—POMC—kidney cancer	2.8e-06	3.46e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3CA—kidney cancer	2.75e-06	3.39e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GSTP1—kidney cancer	2.66e-06	3.28e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—POMC—kidney cancer	2.62e-06	3.23e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PTEN—kidney cancer	2.58e-06	3.19e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PTGS2—kidney cancer	2.57e-06	3.17e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PTGS2—kidney cancer	2.55e-06	3.15e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ABCB1—kidney cancer	2.52e-06	3.11e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.46e-06	3.05e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GSTM1—kidney cancer	2.44e-06	3.02e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.32e-06	2.86e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PTGS2—kidney cancer	2.29e-06	2.83e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PTEN—kidney cancer	2.24e-06	2.76e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—POMC—kidney cancer	2.24e-06	2.76e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PTGS2—kidney cancer	2.23e-06	2.76e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PTEN—kidney cancer	2.22e-06	2.75e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PTGS2—kidney cancer	2.09e-06	2.58e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PTEN—kidney cancer	2e-06	2.47e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PTEN—kidney cancer	1.95e-06	2.41e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.82e-06	2.25e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PTEN—kidney cancer	1.82e-06	2.25e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PTGS2—kidney cancer	1.78e-06	2.2e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—POMC—kidney cancer	1.73e-06	2.13e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.58e-06	1.95e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CA—kidney cancer	1.57e-06	1.94e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PTEN—kidney cancer	1.56e-06	1.92e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.41e-06	1.74e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PTGS2—kidney cancer	1.38e-06	1.7e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CA—kidney cancer	1.37e-06	1.7e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.28e-06	1.59e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PTEN—kidney cancer	1.2e-06	1.48e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.1e-06	1.36e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CA—kidney cancer	8.47e-07	1.05e-05	CbGpPWpGaD
